(Q34106906)

31 July 2017

1 reference

title

Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine (English)

1 reference

31 July 2017

1 reference

Bai XF

1

1 reference

31 July 2017

Link H

series ordinal

2

1 reference

31 July 2017

publication date

1 December 2000

1 reference

Clinical & Experimental Allergy

31 July 2017

published in

1 reference

31 July 2017

volume

30

1 reference

31 July 2017

issue

12

1 reference

31 July 2017

page(s)

1688-1696

1 reference

T cell recognition as the target for immune intervention in autoimmune disease

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Antigen therapy eliminates T cell inflammation by apoptosis: effective treatment of experimental autoimmune neuritis with recombinant myelin protein P2

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Treatment of autoimmune disease by oral tolerance to autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Mucosal tolerance: a two-edged sword to prevent and treat autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

The role of nasopharyngeal lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Defence against allergic sensitization in the healthy lung: the role of inhalation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Induction of experimental allergic encephalomyelitis in Lewis rats with purified synthetic peptides: delineation of antigenic determinants for encephalitogenicity, in vitro activation of cellular transfer, and proliferation of lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Synthetic peptides fail to induce nasal tolerance to experimental autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Treatment with P2 protein peptide 57-81 by nasal route is effective in Lewis rat experimental autoimmune neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Antigen-driven bystander suppression after oral administration of antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8(-) thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Peripheral autoantigen induces regulatory T cells that prevent autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Determinant spreading and the dynamics of the autoimmune T-cell repertoire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2000.00972.X

10.1046/J.1365-2222.2000.00972.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference